|
|
|
|
|
Delaware
|
|
95-3359658
|
|
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
One Park Place,
|
Suite 600
|
|
|
Dublin,
|
CA
|
|
94568
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock par value $0.000025 per share
|
TNET
|
New York Stock Exchange
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
|
|
|
|
|
|
Smaller reporting company
|
☐
|
Emerging growth company
|
☐
|
|
|
|
TABLE OF CONTENTS
|
|
|
Form 10-K
Cross Reference
|
Page
|
|
||
Part I, Item 1.
|
||
Part I, Item 1A.
|
||
Part I, Item 1B.
|
||
Part I, Item 2.
|
||
Part I, Item 3.
|
||
Part I, Item 4.
|
||
Part II, Item 5.
|
||
Part II, Item 6.
|
||
Part II, Item 7.
|
||
Part II, Item 7A.
|
||
Part II, Item 8.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Part II, Item 9.
|
||
Part II, Item 9A.
|
||
Part II, Item 9B.
|
||
Part III, Item 10.
|
||
Part III, Item 11.
|
||
Part III, Item 12.
|
||
Part III, Item 13.
|
||
Part III, Item 14.
|
||
Part IV, Item 15.
|
||
Part IV, Item 16.
|
||
|
|
|
|
GLOSSARY
|
|
AB5
|
Assembly Bill 5
|
ACA
|
The Patient Protection and Affordable Care Act
|
ACH
|
Automated Clearinghouse Transaction
|
AFS
|
Available-for-sale
|
ASC
|
Accounting standards codification
|
ASU
|
Accounting standards update
|
CCPA
|
California Consumer Privacy Act of 2018
|
COBRA
|
Consolidated Omnibus Budget Reconciliation Act
|
COPS
|
Cost of providing services
|
COSO
|
Committee of Sponsoring Organizations of Treadway Commission
|
D&A
|
Depreciation and amortization expenses
|
DOL
|
U.S. Department of Labor
|
EBITDA
|
Earnings before interest expense, taxes, depreciation and amortization of intangible assets
|
EPLI
|
Employment Practices Liability Insurance
|
EPS
|
Earnings Per Share
|
ERISA
|
Employee Retirement Income Security Act of 1974
|
ESAC
|
Employer Services Assurance Corporation
|
ESPP
|
Employee stock purchase plan
|
ETR
|
Effective tax rate
|
FASB
|
Financial Accounting Standards Board
|
FLSA
|
Fair Labor Standards Act
|
G&A
|
General and administrative
|
GAAP
|
Generally Accepted Accounting Principles in the United States
|
HIPAA
|
Health Insurance Portability and Accountability Act of 1996
|
HITECH Act
|
Health Information Technology for Economic and Clinical Health Act of 2009
|
HR
|
Human Resources
|
IBNP
|
Incurred but not yet paid
|
IBNR
|
Incurred but not yet reported
|
IGP
|
Indemnity Guarantee Payment
|
IRS
|
Internal Revenue Service
|
ISR
|
Insurance service revenues
|
LDF
|
Loss development factor
|
LIBOR
|
London Inter-bank Offered Rate
|
MCT
|
Medical cost trend
|
MD&A
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
NIM
|
Net Insurance Margin
|
NISR
|
Net Insurance Service Revenues
|
NSR
|
Net service revenues
|
OE
|
Operating expenses
|
|
|
|
GLOSSARY
|
|
PCAOB
|
Public Company Accounting Oversight Board
|
PEO
|
Professional Employer Organization
|
PFC
|
Payroll funds collected
|
PHI
|
Protected Health Information
|
PSR
|
Professional service revenues
|
ROU
|
Right-of-use
|
RSA
|
Restricted Stock Award
|
RSU
|
Restricted Stock Unit
|
SBC
|
Stock Based Compensation
|
S&M
|
Sales and marketing
|
S&P 500
|
Standard and Poor's 500 Stock Index
|
SD&P
|
Systems development and programming
|
SEC
|
Securities and Exchange Commission
|
SMB
|
Small to midsize business
|
TCJA
|
Tax Cuts and Jobs Act of 2017
|
U.S.
|
United States
|
WSE
|
Worksite employee
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
|
|
|
|
|
|
|
|
|
HR CONSULTING EXPERTISE
|
|
BENEFIT
OPTIONS
|
|
PAYROLL SERVICES
|
|
RISK MITIGATION
|
|
TECHNOLOGY
PLATFORM |
|
|
|
|
|
|
|
|
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
•
|
payments of salaries, wages and certain other compensation to WSEs from our own bank accounts (based on client reports and payments), including the processing of garnishment and wage deduction orders,
|
•
|
reporting of wages, withholding and deposit of associated payroll taxes as the employer of record,
|
•
|
provision and maintenance of workers' compensation insurance and workers' compensation claims processing,
|
•
|
access to, and administration of, group health, welfare, and retirement benefits to WSEs under TriNet-sponsored benefit plans,
|
•
|
compliance with applicable law for certain employee benefits offered to WSEs,
|
•
|
administration of unemployment claims, and
|
•
|
provision of various HR policies and agreements, including employee handbooks and worksite employee agreements describing the co-employment relationship.
|
•
|
day-to-day management of their worksites and WSEs,
|
•
|
compliance with laws associated with the classification of employees as exempt or non-exempt, such as overtime pay and minimum wage law compliance,
|
•
|
accurate and timely reporting to TriNet of compensation and deduction information, including information relating to hours worked, rates of pay, salaries, wages and other compensation, and work locations,
|
•
|
accurate and timely reporting to TriNet of information relating to workplace injuries, employee hires and termination, and certain other information relevant to TriNet’s services,
|
•
|
provision and administration of any employee benefits not provided by TriNet such as equity incentive plans,
|
•
|
compliance with all laws and regulations applicable to the clients' workplace and business, including work eligibility laws, laws relating to workplace safety or the environment, laws relating to family and medical leave, laws pertaining to employee organizing efforts and collective bargaining and employee termination notice requirements,
|
•
|
payment of TriNet invoices, which include salary, wages and other relevant compensation to WSEs and applicable employment taxes and service fees, and
|
•
|
all other matters for which TriNet does not assume responsibility under the client service agreement, such as intellectual property ownership and protection and liability for products produced and services provided by the client company to its own customers.
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
|
|
|
BUSINESS
|
|
•
|
Clients generally change their payroll service providers at the beginning of the payroll tax year; as a result, we have historically experienced our highest volumes of new and exiting clients in the month of January.
|
•
|
WSEs select our benefit products during their respective open enrollment periods, which occur throughout the year. We have historically experienced the largest proportion of WSE benefit changes in the first and fourth quarters.
|
•
|
Health claims cost tend to increase throughout the year as the utilization of medical services above each WSE's deductible causes our insurance costs to increase. In addition, the overall use of medical services by WSEs, including elective procedures, tends to increase later in the calendar year.
|
•
|
Certain payroll tax related billings are based on the WSE's annual taxable wage base up to a set cap. WSEs frequently meet these wage base caps in the first two quarters of the year, depending on the WSE's compensation level, resulting in lower related billing contributions to PSR in the latter half of the year.
|
•
|
PEOs that compete directly with us,
|
•
|
HR and information systems departments and personnel of companies that administer employee benefits, payroll and HR for their companies in-house,
|
•
|
providers of certain endpoint HR services, including payroll, employee benefits, business process outsourcers with high-volume transaction and administrative capabilities, and other third-party administrators,
|
•
|
employee benefit exchanges that provide benefits administration services over the Internet to companies that otherwise maintain their own employee benefit plans,
|
•
|
alternative and non-traditional benefit providers, and
|
•
|
insurance brokers who allow third-party HR systems to integrate with their technology platform.
|
|
|
|
BUSINESS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
•
|
over-valuing and over-paying for businesses and technologies,
|
•
|
increased operating costs and unanticipated costs to successfully integrate the clients, WSEs, operations, systems, technologies, services and personnel of the acquired business,
|
•
|
establishing or maintaining required internal controls, procedures and policies for the acquired business,
|
•
|
diversion of management’s attention from other business concerns,
|
•
|
litigation resulting from the activities of the acquired business,
|
•
|
insufficient revenues, insurance or seller indemnification to offset increased expenses associated with the acquisitions and unanticipated liabilities of the acquired businesses,
|
•
|
entering markets in which we have no prior experience and may not succeed,
|
•
|
potential loss of key employees or key clients of the acquired business as a result of the acquisition or integration of the acquired business.
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
•
|
reduce or eliminate the value and benefits that customers realize by using our products and services,
|
•
|
change or eliminate the types of products and services we provide,
|
•
|
require us to make significant changes to how we do business and provide products and services,
|
•
|
affect the extent and type of employee benefits that employers and co-employers can or must provide employees,
|
•
|
alter the amount, timing and type of taxes employers, co-employers and employees are required to pay and that we are able to manage for our clients
|
•
|
increase the cost and complexity of the licensing requirements for our business operations,
|
•
|
create or increase our liability and responsibilities to our clients and WSEs, and/or
|
•
|
mandate new compliance requirements, disclosures or services.
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
|
|
|
RISK FACTORS
|
|
•
|
the volume and severity of health and workers' compensation insurance claims made by our WSEs, recorded as part of our insurance costs, and the timing of related claims information provided by our insurance carriers,
|
•
|
the amount and timing of our insurance premiums and other insurance costs, operating expenses and capital expenditures,
|
•
|
the number of our new clients and the number of WSEs employed by each new client,
|
•
|
the retention or loss of existing clients, for any reason, including third-party acquisition,
|
•
|
a reduction in the number of WSEs employed by existing clients,
|
•
|
the timing of client payments and payment defaults by clients,
|
•
|
the costs associated with our acquisitions of companies, assets and technologies,
|
•
|
any payments or draw downs on our credit facility,
|
•
|
any unanticipated expenses, such as litigation or other dispute-related settlement payments and compliance expenses arising from changes in regulations or regulatory enforcement,
|
•
|
any expenses we incur for geographic and service expansion and product and service enhancements,
|
•
|
any changes in laws or adverse interpretation or enforcement of laws, which may require us to change the manner in which we operate and/or increase our regulatory compliance costs,
|
•
|
any changes in our effective tax rate,
|
•
|
the issuance of common stock or debt to pay for future acquisitions, which could dilute our stockholders or subject us to significant debt service obligations,
|
•
|
amortization expense, or the impairment of intangible assets and goodwill, associated with past or future acquisitions, and
|
•
|
the impact of new accounting pronouncements.
|
•
|
the overall performance of the equity markets,
|
•
|
any trading activity, or a market expectation regarding such activity, by our directors, executive officers and significant stockholders,
|
•
|
the economy as a whole, and its impact on SMBs and our clients,
|
•
|
the performance and market perception of companies that investors believe are similar to us, and
|
•
|
any significant changes in the liquidity of our common stock.
|
|
|
|
RISK FACTORS
|
|
•
|
incur, assume or prepay debt or incur or assume liens,
|
•
|
pay dividends or distributions or redeem or repurchase capital stock,
|
•
|
make loans, investments or acquisitions,
|
•
|
enter into sale-leaseback transactions,
|
•
|
enter into new lines of business,
|
•
|
complete a significant corporate transaction, such as a merger or sale of our company or its assets, and
|
•
|
enter into agreements that prohibit the incurrence of liens or the payment by our subsidiaries of dividends and distributions.
|
|
|
|
PROPERTIES, LEGAL PROCEEDINGS AND MINE SAFETY DISCLOSURES
|
Corporate:
|
Principal Client Service Centers:
|
• Dublin, California
|
• Bradenton, Florida
|
|
• Reno, Nevada
|
|
• Indian Land, South Carolina
|
|
|
|
STOCK ACTIVITIES
|
|
|
|
|
STOCK ACTIVITIES
|
|
Automatic Data Processing, Inc.
|
Insperity, Inc.
|
Paychex, Inc.
|
Barrett Business Services, Inc.
|
Intuit, Inc.
|
|
|
|
|
STOCK ACTIVITIES
|
|
Period
|
Total Number of
Shares Purchased (1)
|
Weighted Average Price
Paid Per Share
|
Total Number of
Shares
Purchased as Part of Publicly
Announced Plans (2)
|
Approximate Dollar Value
of Shares that May Yet Be Purchased
Under the Plans
(in millions) (2)
|
||||||
October 1- October 31, 2019
|
156,425
|
|
$
|
55.89
|
|
156,285
|
|
$
|
283
|
|
November 1 - November 30, 2019
|
554,910
|
|
$
|
53.79
|
|
488,765
|
|
$
|
257
|
|
December 1 - December 31, 2019
|
513,349
|
|
$
|
55.55
|
|
382,671
|
|
$
|
236
|
|
Total
|
1,224,684
|
|
|
1,027,721
|
|
|
|
|
|
SELECTED FINANCIAL DATA
|
|
|
Year Ended December 31,
|
||||||||||||||
(in millions, except per share data)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Income Statement Data:
|
|
|
|
|
|
||||||||||
Total revenues
|
$
|
3,856
|
|
$
|
3,503
|
|
$
|
3,275
|
|
$
|
3,060
|
|
$
|
2,659
|
|
Net income
|
212
|
|
192
|
|
178
|
|
61
|
|
32
|
|
|||||
Diluted net income per share of common stock
|
2.99
|
|
2.65
|
|
2.49
|
|
0.85
|
|
0.44
|
|
|||||
Non-GAAP measures (1):
|
|
|
|
|
|
||||||||||
Net Service Revenues
|
929
|
|
893
|
|
809
|
|
646
|
|
547
|
|
|||||
Net Insurance Service Revenues
|
399
|
|
406
|
|
351
|
|
199
|
|
146
|
|
|||||
Adjusted EBITDA
|
378
|
|
347
|
|
285
|
|
185
|
|
151
|
|
|||||
Adjusted Net Income
|
236
|
|
218
|
|
142
|
|
87
|
|
71
|
|
|||||
|
|
|
|
|
|
||||||||||
Balance Sheet Data:
|
|
|
|
|
|
||||||||||
Working capital
|
228
|
|
221
|
|
234
|
|
156
|
|
112
|
|
|||||
Total assets
|
2,748
|
|
2,435
|
|
2,593
|
|
2,095
|
|
2,092
|
|
|||||
Long-term debt
|
391
|
|
413
|
|
423
|
|
459
|
|
494
|
|
|||||
Total stockholders’ equity
|
475
|
|
375
|
|
206
|
|
35
|
|
8
|
|
|||||
|
|
|
|
|
|
||||||||||
Cash Flow Data:
|
|
|
|
|
|
||||||||||
Net cash (used in) provided by operating activities
|
$
|
471
|
|
$
|
(104
|
)
|
$
|
606
|
|
$
|
192
|
|
$
|
(281
|
)
|
Net cash (used in) investing activities
|
(188
|
)
|
(200
|
)
|
(24
|
)
|
(27
|
)
|
(38
|
)
|
|||||
Net cash (used in) financing activities
|
(176
|
)
|
(85
|
)
|
(77
|
)
|
(104
|
)
|
(81
|
)
|
|||||
Non-GAAP measures (1):
|
|
|
|
|
|
||||||||||
Corporate operating cash flows
|
233
|
|
234
|
|
299
|
|
189
|
|
169
|
|
(1)
|
Refer to Non-GAAP Financial Measures section on the following pages for definitions and reconciliations from GAAP measures.
|
|
|
|
SELECTED FINANCIAL DATA
|
|
|
|
|
SELECTED FINANCIAL DATA
|
|
Adjusted Net Income
|
• Net income, excluding the effects of:
- effective income tax rate (1),
- stock based compensation,
- amortization of intangible assets,
- non-cash interest expense (2), and
- the income tax effect (at our effective tax rate (1)) of these pre-tax adjustments.
|
• Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges.
|
Corporate Operating Cash Flows
|
• Net cash (used in) provided by operating activities, excluding the effects of:
- Assets associated with WSEs (accounts receivable, unbilled revenue, prepaid expenses and other current assets) and
- Liabilities associated with WSEs (client deposits, accrued wages, payroll tax liabilities and other payroll withholdings, accrued health benefit costs, accrued workers' compensation costs, insurance premiums and other payables, and other current liabilities).
|
• Provides information that our stockholders and management can use to evaluate our cash flows from operations independent of the current assets and liabilities associated with our WSEs.
• Enhances comparisons to prior periods and, accordingly, used as a liquidity measure to manage liquidity between corporate and WSE related activities, and to help determine and plan our cash flow and capital strategies.
|
(1)
|
We have adjusted our non-GAAP effective tax rate to 25.5%, 26%, 41%, 43% and 42% for 2019, 2018, 2017, 2016 and 2015, respectively. The change in 2018 is due primarily to a decrease in the statutory tax rate from 35% to 21%. The changes in 2017, 2016 and 2015 are a result of changes in state income taxes from an increase in excludable income for state income tax purposes or state legislative changes. These non-GAAP effective tax rates exclude the income tax impact from stock based compensation, changes in uncertain tax positions and nonrecurring benefits or expenses from federal legislative changes.
|
(2)
|
Non-cash interest expense represents amortization and write-off of our debt issuance costs.
|
|
Year Ended December 31,
|
||||||||||||||
(in millions)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Total revenues
|
$
|
3,856
|
|
$
|
3,503
|
|
$
|
3,275
|
|
$
|
3,060
|
|
$
|
2,659
|
|
Less: Insurance costs
|
2,927
|
|
2,610
|
|
2,466
|
|
2,414
|
|
2,112
|
|
|||||
Net Service Revenues
|
$
|
929
|
|
$
|
893
|
|
$
|
809
|
|
$
|
646
|
|
$
|
547
|
|
|
Year Ended December 31,
|
||||||||||||||
(in millions)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Insurance service revenues
|
$
|
3,326
|
|
$
|
3,016
|
|
$
|
2,817
|
|
$
|
2,613
|
|
$
|
2,258
|
|
Less: Insurance costs
|
2,927
|
|
2,610
|
|
2,466
|
|
2,414
|
|
2,112
|
|
|||||
Net Insurance Service Revenues
|
$
|
399
|
|
$
|
406
|
|
$
|
351
|
|
$
|
199
|
|
$
|
146
|
|
NIM
|
12
|
%
|
13
|
%
|
12
|
%
|
8
|
%
|
6
|
%
|
|
Year Ended December 31,
|
||||||||||||||
(in millions)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
$
|
61
|
|
$
|
32
|
|
Provision for income taxes
|
58
|
|
49
|
|
22
|
|
43
|
|
28
|
|
|||||
Stock based compensation
|
41
|
|
44
|
|
32
|
|
26
|
|
18
|
|
|||||
Interest expense and bank fees
|
21
|
|
22
|
|
20
|
|
20
|
|
19
|
|
|||||
Depreciation and amortization of intangible assets
|
46
|
|
40
|
|
33
|
|
35
|
|
54
|
|
|||||
Adjusted EBITDA
|
$
|
378
|
|
$
|
347
|
|
$
|
285
|
|
$
|
185
|
|
$
|
151
|
|
Adjusted EBITDA Margin
|
41
|
%
|
39
|
%
|
35
|
%
|
29
|
%
|
28
|
%
|
|
|
|
SELECTED FINANCIAL DATA
|
|
|
Year Ended December 31,
|
||||||||||||||
(in millions)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
$
|
61
|
|
$
|
32
|
|
Effective income tax rate adjustment
|
(11
|
)
|
(13
|
)
|
(59
|
)
|
(1
|
)
|
3
|
|
|||||
Stock based compensation
|
41
|
|
44
|
|
32
|
|
26
|
|
18
|
|
|||||
Amortization of intangible assets
|
5
|
|
5
|
|
5
|
|
16
|
|
39
|
|
|||||
Non-cash interest expense
|
1
|
|
4
|
|
2
|
|
4
|
|
4
|
|
|||||
Income tax impact of pre-tax adjustments
|
(12
|
)
|
(14
|
)
|
(16
|
)
|
(19
|
)
|
(25
|
)
|
|||||
Adjusted Net Income
|
$
|
236
|
|
$
|
218
|
|
$
|
142
|
|
$
|
87
|
|
$
|
71
|
|
|
Year Ended December 31,
|
||||||||||||||
(in millions)
|
2019
|
2018
|
2017
|
2016
|
2015
|
||||||||||
Net cash (used in) provided by operating activities
|
$
|
471
|
|
$
|
(104
|
)
|
$
|
606
|
|
$
|
192
|
|
$
|
(281
|
)
|
Change in WSE related other current assets
|
(15
|
)
|
33
|
|
35
|
|
(96
|
)
|
188
|
|
|||||
Change in WSE related liabilities
|
(223
|
)
|
305
|
|
(342
|
)
|
93
|
|
262
|
|
|||||
Corporate Operating Cash Flows
|
$
|
233
|
|
$
|
234
|
|
$
|
299
|
|
$
|
189
|
|
$
|
169
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
experienced an improvement in retention as a result of our customer service initiatives,
|
•
|
benefited from our clients growing their WSEs,
|
•
|
saw an increase in new sales, which delivered additional revenue growth,
|
•
|
continued to experience our WSEs increasing their participation, or enrollment, in our insurance offerings,
|
•
|
experienced increased severity of health costs per enrollee overall, but particularly within a national carrier, and
|
•
|
delivered profitable growth.
|
|
324,927
|
|
340,017
|
|
$41.7B
|
|||||
|
Average WSE
|
|
Total WSE
|
|
Payroll and payroll tax payments
|
|||||
|
2
|
%
|
increase
|
|
4%
|
increase
|
|
11
|
%
|
increase
|
|
|
|
|
|
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Year Ended December 31,
|
% Change
|
|||||||||||
(in millions, except operating metrics data)
|
2019
|
2018
|
2017
|
2019 vs. 2018
|
2018 vs. 2017
|
||||||||
Income Statement Data:
|
|
|
|
|
|
||||||||
Professional service revenues
|
$
|
530
|
|
$
|
487
|
|
$
|
458
|
|
9
|
%
|
6
|
%
|
Insurance service revenues
|
3,326
|
|
3,016
|
|
2,817
|
|
10
|
|
7
|
|
|||
Total revenues
|
3,856
|
|
3,503
|
|
3,275
|
|
10
|
|
7
|
|
|||
Insurance costs
|
2,927
|
|
2,610
|
|
2,466
|
|
12
|
|
6
|
|
|||
Operating expenses
|
661
|
|
642
|
|
592
|
|
3
|
|
8
|
|
|||
Total costs and operating expenses
|
3,588
|
|
3,252
|
|
3,058
|
|
10
|
|
6
|
|
|||
Operating income
|
268
|
|
251
|
|
217
|
|
7
|
|
15
|
|
|||
Other income (expense):
|
|
|
|
|
|
||||||||
Interest expense, bank fees and other
|
(21
|
)
|
(22
|
)
|
(20
|
)
|
(5
|
)
|
10
|
|
|||
Interest income
|
23
|
|
12
|
|
3
|
|
92
|
|
300
|
|
|||
Income before provision for income taxes
|
270
|
|
241
|
|
200
|
|
12
|
|
21
|
|
|||
Income taxes
|
58
|
|
49
|
|
22
|
|
18
|
|
128
|
|
|||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
10
|
%
|
8
|
%
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
||||||||
Non-GAAP measures (1):
|
|
|
|
|
|
||||||||
Net Service Revenues
|
$
|
929
|
|
$
|
893
|
|
$
|
809
|
|
4
|
%
|
10
|
%
|
Net Insurance Service Revenues
|
399
|
|
406
|
|
351
|
|
(2
|
)
|
16
|
|
|||
Adjusted EBITDA
|
378
|
|
347
|
|
285
|
|
9
|
|
22
|
|
|||
Adjusted Net income
|
236
|
|
218
|
|
142
|
|
8
|
|
53
|
|
|||
|
|
|
|
|
|
||||||||
Operating Metrics:
|
|
|
|
|
|
||||||||
Average WSEs
|
324,927
|
|
317,104
|
|
324,679
|
|
2
|
%
|
(2
|
)%
|
|||
Total WSEs
|
340,017
|
|
325,616
|
|
325,370
|
|
4
|
|
—
|
|
|||
Total WSEs payroll and payroll taxes processed (in millions)
|
$
|
41,682
|
|
$
|
37,666
|
|
$
|
37,115
|
|
11
|
|
1
|
|
(1)
|
Refer to Non-GAAP measures definitions and reconciliations from GAAP measures in Part II, Item 6. Selected Financial Data.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
•
|
Rate - the combined weighted average percentage changes in service fees for each vertical product and changes in service fees associated with each insurance service offering, and
|
•
|
Mix - the change in composition of Average WSEs within our verticals combined with the composition of our enrolled WSEs within our insurance service offerings.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
•
|
Rate - the weighted average percentage change in fees for each vertical, and
|
•
|
Mix - the change in composition of Average WSEs across our verticals.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
•
|
Rate - the weighted average percentage change in fees associated with each of our insurance service offerings, and
|
•
|
Mix - all other changes including the composition of our enrolled WSEs within our insurance service offerings (health plan enrollment).
|
•
|
Volume - the percentage change in period over period Average WSEs,
|
•
|
Rate - the weighted average percentage change in cost trend associated with each of our insurance service offerings, and
|
•
|
Mix - all other changes including the composition of our enrolled WSEs within our insurance service offerings (health plan enrollment).
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
Increased severity of health costs per enrollee (medical cost trend) of 10.5% - 11.5% in 2019, particularly within one national carrier, arising from a shift in pharmaceutical utilization from brand name drugs to higher cost specialty drugs, combined with elevated health costs in a portion of this business, partially offset by lower health administrative costs.
|
•
|
Partially offset by an $11 million decrease in workers' compensation claim costs.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
December 31,
|
|||||||||||||||||
|
2019
|
2018
|
||||||||||||||||
(in millions)
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
Current assets:
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
$
|
213
|
|
$
|
—
|
|
$
|
213
|
|
$
|
228
|
|
$
|
—
|
|
$
|
228
|
|
Investments
|
68
|
|
—
|
|
68
|
|
54
|
|
—
|
|
54
|
|
||||||
Restricted cash, cash equivalents and investments
|
15
|
|
1,165
|
|
1,180
|
|
15
|
|
927
|
|
942
|
|
||||||
Other current assets
|
45
|
|
365
|
|
410
|
|
36
|
|
386
|
|
422
|
|
||||||
Total current assets
|
$
|
341
|
|
$
|
1,530
|
|
$
|
1,871
|
|
$
|
333
|
|
$
|
1,313
|
|
$
|
1,646
|
|
Total current liabilities
|
$
|
113
|
|
$
|
1,530
|
|
$
|
1,643
|
|
$
|
112
|
|
$
|
1,313
|
|
$
|
1,425
|
|
Working capital
|
$
|
228
|
|
$
|
—
|
|
$
|
228
|
|
$
|
221
|
|
$
|
—
|
|
$
|
221
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Year Ended December 31,
|
|||||||||||||||||
(in millions)
|
2019
|
2018
|
||||||||||||||||
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
Net cash provided by (used in):
|
|
|
|
|
|
|
||||||||||||
Operating activities
|
$
|
233
|
|
$
|
238
|
|
$
|
471
|
|
$
|
234
|
|
$
|
(338
|
)
|
$
|
(104
|
)
|
Investing activities
|
(191
|
)
|
3
|
|
(188
|
)
|
(200
|
)
|
—
|
|
(200
|
)
|
||||||
Financing activities
|
(176
|
)
|
—
|
|
(176
|
)
|
(85
|
)
|
—
|
|
(85
|
)
|
||||||
Net increase (decrease) in cash and cash equivalents, unrestricted and restricted
|
$
|
(134
|
)
|
$
|
241
|
|
$
|
107
|
|
$
|
(51
|
)
|
$
|
(338
|
)
|
$
|
(389
|
)
|
Cash and cash equivalents, unrestricted and restricted:
|
|
|
|
|
|
|
||||||||||||
Beginning of period
|
$
|
425
|
|
$
|
924
|
|
$
|
1,349
|
|
$
|
476
|
|
$
|
1,262
|
|
$
|
1,738
|
|
End of period
|
$
|
291
|
|
$
|
1,165
|
|
$
|
1,456
|
|
$
|
425
|
|
$
|
924
|
|
$
|
1,349
|
|
|
|
|
|
|
|
|
||||||||||||
Net increase (decrease) in cash and cash equivalents:
|
|
|
|
|
|
|
||||||||||||
Unrestricted
|
$
|
(15
|
)
|
$
|
—
|
|
$
|
(15
|
)
|
$
|
(108
|
)
|
$
|
—
|
|
$
|
(108
|
)
|
Restricted
|
(119
|
)
|
241
|
|
122
|
|
57
|
|
(338
|
)
|
(281
|
)
|
|
Year Ended December 31,
|
|||||
(in millions)
|
2019
|
2018
|
||||
Net income
|
$
|
212
|
|
$
|
192
|
|
Depreciation and amortization
|
57
|
|
46
|
|
||
Noncash lease expense
|
16
|
|
—
|
|
||
Stock based compensation expense
|
41
|
|
44
|
|
||
Payment of interest
|
(19
|
)
|
(17
|
)
|
||
Income tax payments, net
|
(62
|
)
|
(49
|
)
|
||
Changes in deferred taxes
|
(7
|
)
|
1
|
|
||
Changes in other operating assets
|
(36
|
)
|
(44
|
)
|
||
Changes in other operating liabilities
|
31
|
|
61
|
|
||
Net cash provided by operating activities - Corporate
|
$
|
233
|
|
$
|
234
|
|
Collateral (paid to) refunded from insurance carriers, net
|
6
|
|
26
|
|
||
Changes in other operating assets
|
15
|
|
(27
|
)
|
||
Changes in other operating liabilities
|
217
|
|
(337
|
)
|
||
Net cash (used in) provided by operating activities - WSE
|
$
|
238
|
|
$
|
(338
|
)
|
Net cash (used in) provided by operating activities
|
$
|
471
|
|
$
|
(104
|
)
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Year Ended December 31,
|
|||||
(in millions)
|
2019
|
2018
|
||||
Investments:
|
|
|
||||
Purchases of investments
|
$
|
(302
|
)
|
$
|
(258
|
)
|
Proceeds from sale and maturity of investments
|
159
|
|
101
|
|
||
Cash used in investments
|
$
|
(143
|
)
|
$
|
(157
|
)
|
|
|
|
||||
Capital expenditures:
|
|
|
||||
Software and hardware
|
$
|
(34
|
)
|
$
|
(30
|
)
|
Office furniture, equipment and leasehold improvements
|
(11
|
)
|
(13
|
)
|
||
Cash used in capital expenditures
|
$
|
(45
|
)
|
$
|
(43
|
)
|
Cash used in investing activities
|
$
|
(188
|
)
|
$
|
(200
|
)
|
|
Year Ended December 31,
|
|||||
(in millions)
|
2019
|
2018
|
||||
Financing activities
|
|
|
||||
Repurchase of common stock, net of issuance
|
$
|
(154
|
)
|
$
|
(69
|
)
|
Repayment of borrowings
|
(22
|
)
|
(22
|
)
|
||
Net proceeds from issuance of debt
|
—
|
|
6
|
|
||
Cash used in financing activities
|
$
|
(176
|
)
|
$
|
(85
|
)
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Payments Due by Period
|
||||||||||||||
(in millions)
|
Total
|
Less than 1 year
|
1-3 years
|
3-5 years
|
More than 5 years
|
||||||||||
Debt obligations (1)
|
$
|
392
|
|
$
|
22
|
|
$
|
44
|
|
$
|
326
|
|
$
|
—
|
|
Workers' compensation obligations (2)
|
217
|
|
66
|
|
49
|
|
34
|
|
68
|
|
|||||
Operating lease obligations (3)
|
74
|
|
19
|
|
21
|
|
15
|
|
19
|
|
|||||
Purchase obligations (4)
|
60
|
|
34
|
|
22
|
|
4
|
|
—
|
|
|||||
Uncertain tax positions (5)
|
7
|
|
1
|
|
6
|
|
—
|
|
—
|
|
|||||
Total
|
$
|
750
|
|
$
|
142
|
|
$
|
142
|
|
$
|
379
|
|
$
|
87
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
the selection of method used and the relative weights given to selecting the method used for each policy year,
|
•
|
the underlying assumptions of LDF used in these models,
|
•
|
the effect of any changes to the insurers' claims handling and payment processes,
|
•
|
evaluation of medical and indemnity cost trends, costs from changes in the risk exposure being evaluated and any applicable changes in legal, regulatory or judicial environment.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
•
|
Historical volume and severity of workers' compensation cost experience, exposure data and industry loss experience related to TriNet’s insurance policies,
|
•
|
inputs of WSEs’ job responsibilities and location,
|
•
|
estimates of future cost trends,
|
•
|
expected loss ratios for the latest accident year or prior accident years, adjusted for the loss trend, the effect of rate changes and other quantifiable factors, and
|
•
|
LDFs to project the reported losses for each accident year to an ultimate basis.
|
•
|
historical loss claims payment patterns and medical cost trend rates related to TriNet’s insurance policies,
|
•
|
current period claims costs and claims reporting patterns (completion factors), and
|
•
|
plan enrollment.
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
Change in medical cost trend
|
Change in insurance costs
|
+3.0%
|
$18
|
+2.0%
|
$12
|
+1.0%
|
$6
|
-1.0%
|
$(6)
|
-2.0%
|
$(12)
|
-3.0%
|
$(18)
|
|
|
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
We tested the effectiveness of controls related to accrued workers’ compensation and health insurance costs.
|
•
|
We tested the underlying data that served as inputs into the actuarial analyses, including testing historical claims and enrollment data and recreating the claim loss triangles.
|
•
|
With the assistance of our actuarial specialists, we evaluated the methods and assumptions used by management to estimate the accrued workers’ compensation and health insurance costs:
|
◦
|
Compared management’s prior-year assumptions of expected development and ultimate loss to actuals incurred during the current year to identify and evaluate potential bias in the determination of the accrued workers’ compensation and health insurance costs.
|
◦
|
Developed an independent range of estimates of the accrued costs, utilizing loss development factors and future cost trends for accrued workers’ compensation costs and claim payment patterns and medical trend rates for accrued health insurance costs. We compared our estimated ranges to management’s estimates.
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions except per share data)
|
2019
|
2018
|
2017
|
||||||
Professional service revenues
|
$
|
530
|
|
$
|
487
|
|
$
|
458
|
|
Insurance service revenues
|
3,326
|
|
3,016
|
|
2,817
|
|
|||
Total revenues
|
3,856
|
|
3,503
|
|
3,275
|
|
|||
Insurance costs
|
2,927
|
|
2,610
|
|
2,466
|
|
|||
Cost of providing services
|
245
|
|
229
|
|
213
|
|
|||
Sales and marketing
|
190
|
|
182
|
|
187
|
|
|||
General and administrative
|
137
|
|
142
|
|
114
|
|
|||
Systems development and programming
|
43
|
|
49
|
|
45
|
|
|||
Depreciation and amortization of intangible assets
|
46
|
|
40
|
|
33
|
|
|||
Total costs and operating expenses
|
3,588
|
|
3,252
|
|
3,058
|
|
|||
Operating income
|
268
|
|
251
|
|
217
|
|
|||
Other income (expense):
|
|
|
|
||||||
Interest expense, bank fees and other
|
(21
|
)
|
(22
|
)
|
(20
|
)
|
|||
Interest income
|
23
|
|
12
|
|
3
|
|
|||
Income before provision for income taxes
|
270
|
|
241
|
|
200
|
|
|||
Income taxes
|
58
|
|
49
|
|
22
|
|
|||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
Comprehensive income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
|
|
|
|
||||||
Net income per share:
|
|
|
|
||||||
Basic
|
$
|
3.04
|
|
$
|
2.72
|
|
$
|
2.57
|
|
Diluted
|
$
|
2.99
|
|
$
|
2.65
|
|
$
|
2.49
|
|
Weighted average shares:
|
|
|
|
||||||
Basic
|
70
|
|
70
|
|
69
|
|
|||
Diluted
|
71
|
|
72
|
|
71
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
December 31,
|
|
December 31,
|
||||
(in millions, except share and per share data)
|
|
2019
|
|
2018
|
||||
ASSETS
|
|
|
|
|
||||
Current assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
213
|
|
|
$
|
228
|
|
Investments
|
|
68
|
|
|
54
|
|
||
Restricted cash, cash equivalents and investments
|
|
1,180
|
|
|
942
|
|
||
Accounts receivable, net
|
|
9
|
|
|
11
|
|
||
Unbilled revenue, net
|
|
285
|
|
|
304
|
|
||
Prepaid expenses, net
|
|
52
|
|
|
48
|
|
||
Other current assets
|
|
64
|
|
|
59
|
|
||
Total current assets
|
|
1,871
|
|
|
1,646
|
|
||
Restricted cash, cash equivalents and investments, noncurrent
|
|
212
|
|
|
187
|
|
||
Investments, noncurrent
|
|
125
|
|
|
135
|
|
||
Property, equipment and software, net
|
|
85
|
|
|
79
|
|
||
Operating lease right-of-use asset
|
|
55
|
|
|
—
|
|
||
Goodwill
|
|
289
|
|
|
289
|
|
||
Other intangible assets, net
|
|
15
|
|
|
21
|
|
||
Other assets
|
|
96
|
|
|
78
|
|
||
Total assets
|
|
$
|
2,748
|
|
|
$
|
2,435
|
|
Liabilities and stockholders' equity
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
||||
Accounts payable and other current liabilities
|
|
$
|
31
|
|
|
$
|
45
|
|
Long-term debt
|
|
22
|
|
|
22
|
|
||
Client deposits
|
|
44
|
|
|
56
|
|
||
Accrued wages
|
|
391
|
|
|
352
|
|
||
Accrued health insurance costs, net
|
|
167
|
|
|
135
|
|
||
Accrued workers' compensation costs, net
|
|
61
|
|
|
67
|
|
||
Payroll tax liabilities and other payroll withholdings
|
|
901
|
|
|
729
|
|
||
Operating lease liabilities
|
|
17
|
|
|
—
|
|
||
Insurance premiums and other payables
|
|
9
|
|
|
19
|
|
||
Total current liabilities
|
|
1,643
|
|
|
1,425
|
|
||
Long-term debt, noncurrent
|
|
369
|
|
|
391
|
|
||
Accrued workers' compensation costs, noncurrent, net
|
|
144
|
|
|
158
|
|
||
Deferred taxes
|
|
61
|
|
|
68
|
|
||
Operating lease liabilities, noncurrent
|
|
48
|
|
|
—
|
|
||
Other non-current liabilities
|
|
8
|
|
|
18
|
|
||
Total liabilities
|
|
2,273
|
|
|
2,060
|
|
||
Commitments and contingencies (see Note 10)
|
|
|
|
|
||||
Stockholders' equity:
|
|
|
|
|
||||
Preferred stock
|
|
—
|
|
|
—
|
|
||
($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at December 31, 2019 and 2018)
|
|
|
|
|
||||
Common stock and additional paid-in capital
|
|
694
|
|
|
641
|
|
||
($0.000025 par value per share; 750,000,000 shares authorized; 69,065,491 and 70,596,559 shares issued and outstanding at December 31, 2019 and 2018, respectively)
|
|
|
|
|
||||
Accumulated deficit
|
|
(219
|
)
|
|
(266
|
)
|
||
Total stockholders' equity
|
|
475
|
|
|
375
|
|
||
Total liabilities & stockholders' equity
|
|
$
|
2,748
|
|
|
$
|
2,435
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Total Stockholders' Equity, beginning balance
|
$
|
375
|
|
$
|
206
|
|
$
|
35
|
|
Common Stock and Additional Paid-In Capital:
|
|
|
|
||||||
Beginning balance
|
641
|
|
583
|
|
535
|
|
|||
Issuance of common stock from exercise of stock options
|
2
|
|
7
|
|
11
|
|
|||
Issuance of common stock for employee stock purchase plan
|
9
|
|
7
|
|
5
|
|
|||
Stock based compensation expense
|
42
|
|
44
|
|
32
|
|
|||
Ending balance
|
694
|
|
641
|
|
583
|
|
|||
|
|
|
|
||||||
Accumulated Deficit:
|
|
|
|
||||||
Beginning balance
|
(266
|
)
|
(377
|
)
|
(500
|
)
|
|||
Net income
|
212
|
|
192
|
|
178
|
|
|||
Cumulative effect of accounting change
|
—
|
|
2
|
|
—
|
|
|||
Repurchase of common stock
|
(140
|
)
|
(61
|
)
|
(44
|
)
|
|||
Awards effectively repurchased for required employee withholding taxes
|
(25
|
)
|
(22
|
)
|
(11
|
)
|
|||
Ending balance
|
(219
|
)
|
(266
|
)
|
(377
|
)
|
|||
Total Stockholders' Equity, ending balance
|
$
|
475
|
|
$
|
375
|
|
$
|
206
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Operating activities
|
|
|
|
||||||
Net income
|
$
|
212
|
|
$
|
192
|
|
178
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||||
Depreciation and amortization
|
57
|
|
46
|
|
35
|
|
|||
Noncash lease expense
|
16
|
|
—
|
|
—
|
|
|||
Stock based compensation
|
41
|
|
44
|
|
32
|
|
|||
Deferred income taxes
|
(7
|
)
|
1
|
|
(25
|
)
|
|||
Amortization of (premium) discount of investments
|
(1
|
)
|
—
|
|
—
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
||||||
Accounts receivable, net
|
5
|
|
10
|
|
(14
|
)
|
|||
Unbilled revenue, net
|
19
|
|
(14
|
)
|
(4
|
)
|
|||
Prepaid expenses, net
|
(5
|
)
|
(9
|
)
|
28
|
|
|||
Accounts payable and other current liabilities
|
(15
|
)
|
(8
|
)
|
23
|
|
|||
Client deposits
|
(12
|
)
|
4
|
|
(4
|
)
|
|||
Accrued wages
|
40
|
|
23
|
|
26
|
|
|||
Accrued health insurance costs, net
|
32
|
|
(16
|
)
|
22
|
|
|||
Accrued workers' compensation costs, net
|
(20
|
)
|
(7
|
)
|
9
|
|
|||
Payroll taxes payable and other payroll withholdings
|
172
|
|
(305
|
)
|
294
|
|
|||
Operating lease liabilities
|
(17
|
)
|
—
|
|
—
|
|
|||
Other assets
|
(34
|
)
|
(64
|
)
|
(11
|
)
|
|||
Other liabilities
|
(12
|
)
|
(1
|
)
|
17
|
|
|||
Net cash (used in) provided by operating activities
|
471
|
|
(104
|
)
|
606
|
|
|||
Investing activities
|
|
|
|
||||||
Purchases of marketable securities
|
(302
|
)
|
(258
|
)
|
—
|
|
|||
Proceeds from sale and maturity of marketable securities
|
159
|
|
101
|
|
14
|
|
|||
Acquisitions of property and equipment
|
(45
|
)
|
(43
|
)
|
(38
|
)
|
|||
Net cash used in investing activities
|
(188
|
)
|
(200
|
)
|
(24
|
)
|
|||
Financing activities
|
|
|
|
||||||
Repurchase of common stock
|
(140
|
)
|
(61
|
)
|
(44
|
)
|
|||
Proceeds from issuance of common stock
|
11
|
|
14
|
|
16
|
|
|||
Awards effectively repurchased for required employee withholding taxes
|
(25
|
)
|
(22
|
)
|
(11
|
)
|
|||
Proceeds from issuance of notes payable, net
|
—
|
|
210
|
|
—
|
|
|||
Payments for extinguishment of debt
|
—
|
|
(204
|
)
|
—
|
|
|||
Repayment of debt
|
(22
|
)
|
(22
|
)
|
(38
|
)
|
|||
Net cash used in financing activities
|
(176
|
)
|
(85
|
)
|
(77
|
)
|
|||
Net (decrease) increase in cash and cash equivalents, unrestricted and restricted
|
107
|
|
(389
|
)
|
505
|
|
|||
Cash and cash equivalents, unrestricted and restricted:
|
|
|
|
||||||
Beginning of period
|
1,349
|
|
1,738
|
|
1,233
|
|
|||
End of period
|
$
|
1,456
|
|
$
|
1,349
|
|
$
|
1,738
|
|
|
|
|
|
||||||
Supplemental disclosures of cash flow information
|
|
|
|
||||||
Interest paid
|
$
|
19
|
|
$
|
17
|
|
16
|
|
|
Income taxes paid, net
|
62
|
|
49
|
|
2
|
|
|||
Supplemental schedule of noncash investing and financing activities
|
|
|
|
||||||
Payable for purchase of property and equipment
|
$
|
2
|
|
$
|
3
|
|
2
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
compensation through wages and salaries,
|
•
|
employer payroll-related tax payments,
|
•
|
employee payroll-related tax withholdings and payments,
|
•
|
employee benefit programs, including health and life insurance, and others, and
|
•
|
workers' compensation coverage.
|
•
|
Our annual service contracts with our clients that are cancellable with 30 days' notice are considered 30-day contracts under the new standard;
|
•
|
Professional service revenues are recognized on an output basis which results in recognition at the time payroll is processed;
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
Our non-refundable set up fees are no longer deferred but accounted for as part of our transaction price and are allocated among professional service revenues and insurance services revenues; and
|
•
|
The majority of sales commissions related to onboarding new clients that were previously expensed are capitalized as contract assets and amortized over the estimated client life.
|
•
|
Payroll and payroll tax processing,
|
•
|
Health benefits services, and
|
•
|
Workers’ compensation services.
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
|||||||||||
|
2019
|
2018
|
||||||||||
(in millions)
|
Capitalized
|
Amortized
|
Capitalized
|
Amortized
|
||||||||
Deferred commission expense
|
$
|
45
|
|
$
|
10
|
|
$
|
33
|
|
$
|
2
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
historical loss experience, exposure data, and industry loss experience related to TriNet’s insurance policies,
|
•
|
inputs including WSE job responsibilities and location,
|
•
|
historical volume and severity of workers' compensation claims,
|
•
|
an estimate of future cost trends,
|
•
|
expected loss ratios for the latest accident year or prior accident years, adjusted for the loss trend, the effect of rate changes and other quantifiable factors, and
|
•
|
loss development factors to project the reported losses for each accident year to an ultimate basis.
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
not to reassess 1) whether any contracts that existed prior to adoption have or contain leases, 2) the classification of our existing leases or 3) initial direct costs for existing leases,
|
•
|
to use the practical expedient of using hindsight to determine the lease terms and evaluate any impairments in right-of-use assets upon transition, and
|
•
|
not separately record non-lease and lease components for all leases in which we act as a lessee.
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
cash and cash equivalents in trust accounts functioning as security deposits for our insurance carriers,
|
•
|
payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE payroll and payroll taxes and other payroll related liabilities, and
|
•
|
amounts held in trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.
|
|
|
|
FINANCIAL STATEMENTS
|
|
•
|
Level 1—observable inputs for identical assets or liabilities, such as quoted prices in active markets,
|
•
|
Level 2—inputs other than the quoted prices in active markets that are observable either directly or indirectly,
|
•
|
Level 3—unobservable inputs in which there is little or no market data, which requires that we develop our own assumptions.
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
December 31, 2019
|
||||||||||
(in millions)
|
|
As reported
|
|
Balance Using Previous Standard
|
|
Increase (Decrease)
|
||||||
Balance sheet
|
|
|
|
|
|
|
||||||
Assets
|
|
|
|
|
|
|
||||||
Operating lease right-of-use assets
|
|
$
|
55
|
|
|
$
|
—
|
|
|
$
|
55
|
|
Liabilities
|
|
|
|
|
|
|
||||||
Operating lease liabilities
|
|
17
|
|
|
—
|
|
|
17
|
|
|||
Operating lease liabilities, noncurrent
|
|
48
|
|
|
10
|
|
|
38
|
|
|||
Equity
|
|
|
|
|
|
|
||||||
Accumulated deficit
|
|
(219
|
)
|
|
(219
|
)
|
|
—
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
December 31, 2019
|
December 31, 2018
|
||||||||||||||||||||||
(in millions)
|
Cash and cash equivalents
|
Available-for-sale marketable securities
|
Certificate
of
deposits
|
Total
|
Cash and cash equivalents
|
Available-for-sale marketable securities
|
Certificate
of
deposits
|
Total
|
||||||||||||||||
Cash and cash equivalents
|
$
|
213
|
|
$
|
—
|
|
$
|
—
|
|
$
|
213
|
|
$
|
228
|
|
$
|
—
|
|
$
|
—
|
|
$
|
228
|
|
Investments
|
—
|
|
68
|
|
—
|
|
68
|
|
—
|
|
54
|
|
—
|
|
54
|
|
||||||||
Restricted cash, cash equivalents and investments
|
|
|
|
|
|
|
|
|
||||||||||||||||
Payroll funds collected
|
1,018
|
|
—
|
|
—
|
|
1,018
|
|
783
|
|
—
|
|
—
|
|
783
|
|
||||||||
Collateral for health benefits claims
|
98
|
|
—
|
|
—
|
|
98
|
|
75
|
|
—
|
|
—
|
|
75
|
|
||||||||
Collateral for workers' compensation claims
|
62
|
|
—
|
|
—
|
|
62
|
|
66
|
|
1
|
|
—
|
|
67
|
|
||||||||
Collateral to secure standby letter of credit
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2
|
|
2
|
|
||||||||
Other security deposits
|
2
|
|
—
|
|
—
|
|
2
|
|
15
|
|
—
|
|
—
|
|
15
|
|
||||||||
Total restricted cash, cash equivalents and investments
|
1,180
|
|
—
|
|
—
|
|
1,180
|
|
939
|
|
1
|
|
2
|
|
942
|
|
||||||||
Investments, noncurrent
|
—
|
|
125
|
|
—
|
|
125
|
|
—
|
|
135
|
|
—
|
|
135
|
|
||||||||
Restricted cash, cash equivalents and investments, noncurrent
|
|
|
|
|
|
|
|
|
||||||||||||||||
Collateral for workers' compensation claims
|
63
|
|
148
|
|
1
|
|
212
|
|
182
|
|
5
|
|
—
|
|
187
|
|
||||||||
Total
|
$
|
1,456
|
|
$
|
341
|
|
$
|
1
|
|
$
|
1,798
|
|
$
|
1,349
|
|
$
|
195
|
|
$
|
2
|
|
$
|
1,546
|
|
|
December 31, 2019
|
December 31, 2018
|
||||||||||||||||||||||
(in millions)
|
Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
||||||||||||||||
Asset-backed securities
|
$
|
30
|
|
$
|
—
|
|
$
|
—
|
|
$
|
30
|
|
$
|
33
|
|
$
|
—
|
|
$
|
—
|
|
$
|
33
|
|
Corporate bonds
|
123
|
|
1
|
|
—
|
|
124
|
|
99
|
|
—
|
|
—
|
|
99
|
|
||||||||
U.S. government agencies and government-sponsored agencies
|
14
|
|
—
|
|
—
|
|
14
|
|
7
|
|
—
|
|
—
|
|
7
|
|
||||||||
U.S. treasuries
|
163
|
|
—
|
|
—
|
|
163
|
|
46
|
|
—
|
|
—
|
|
46
|
|
||||||||
Exchange traded fund
|
—
|
|
—
|
|
—
|
|
—
|
|
1
|
|
—
|
|
—
|
|
1
|
|
||||||||
Certificates of deposit
|
1
|
|
—
|
|
—
|
|
1
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Other debt securities
|
10
|
|
—
|
|
—
|
|
10
|
|
9
|
|
—
|
|
—
|
|
9
|
|
||||||||
Total
|
$
|
341
|
|
$
|
1
|
|
$
|
—
|
|
$
|
342
|
|
$
|
195
|
|
$
|
—
|
|
$
|
—
|
|
$
|
195
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
(in millions)
|
|
December 31, 2019
|
|
December 31, 2018
|
|
||||
One year or less
|
|
$
|
80
|
|
|
$
|
59
|
|
|
Over one year through five years
|
|
237
|
|
|
120
|
|
|
||
Over five years through ten years
|
|
8
|
|
|
3
|
|
|
||
Over ten years
|
|
17
|
|
|
12
|
|
|
||
Total fair value
|
|
$
|
342
|
|
|
$
|
194
|
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Gross proceeds from sales
|
$
|
76
|
|
$
|
54
|
|
$
|
—
|
|
Gross proceeds from maturities
|
83
|
|
47
|
|
14
|
|
|||
Total
|
$
|
159
|
|
$
|
101
|
|
$
|
14
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
(in millions)
|
Level 1
|
Level 2
|
Total
|
||||||
December 31, 2019
|
|
|
|
||||||
Cash equivalents:
|
|
|
|
||||||
Money market mutual funds
|
$
|
89
|
|
$
|
—
|
|
$
|
89
|
|
U.S. treasuries
|
—
|
|
3
|
|
3
|
|
|||
Total cash equivalents
|
89
|
|
3
|
|
92
|
|
|||
Investments:
|
|
|
|
|
|||||
Asset-backed securities
|
—
|
|
30
|
|
30
|
|
|||
Corporate bonds
|
—
|
|
96
|
|
96
|
|
|||
U.S. government agencies and government-sponsored agencies
|
—
|
|
5
|
|
5
|
|
|||
U.S. treasuries
|
—
|
|
53
|
|
53
|
|
|||
Other debt securities
|
—
|
|
10
|
|
10
|
|
|||
Total investments
|
—
|
|
194
|
|
194
|
|
|||
Restricted cash equivalents:
|
|
|
|
|
|||||
Money market mutual funds
|
42
|
|
—
|
|
42
|
|
|||
U.S. treasuries
|
—
|
|
12
|
|
12
|
|
|||
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
Commercial paper
|
14
|
|
—
|
|
14
|
|
|||
Total restricted cash equivalents
|
56
|
|
14
|
|
70
|
|
|||
Restricted investments:
|
|
|
|
|
|||||
Corporate bonds
|
—
|
|
28
|
|
28
|
|
|||
U.S. government agencies and government-sponsored agencies
|
—
|
|
9
|
|
9
|
|
|||
U.S. treasuries
|
—
|
|
110
|
|
110
|
|
|||
Certificate of deposit
|
—
|
|
1
|
|
1
|
|
|||
Total restricted investments
|
—
|
|
148
|
|
148
|
|
|||
Total investments and restricted cash equivalents and investments
|
$
|
145
|
|
$
|
359
|
|
$
|
504
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
(in millions)
|
Level 1
|
Level 2
|
Total
|
||||||
December 31, 2018
|
|
|
|
||||||
Cash equivalents:
|
|
|
|
||||||
Money market mutual funds
|
$
|
4
|
|
$
|
—
|
|
$
|
4
|
|
U.S. treasuries
|
—
|
|
1
|
|
1
|
|
|||
Total cash equivalents
|
4
|
|
1
|
|
5
|
|
|||
Investments:
|
|
|
|
||||||
Asset-backed securities
|
—
|
|
33
|
|
33
|
|
|||
Corporate bonds
|
—
|
|
99
|
|
99
|
|
|||
U.S. government agencies and government-sponsored agencies
|
—
|
|
7
|
|
7
|
|
|||
U.S. treasuries
|
—
|
|
41
|
|
41
|
|
|||
Other debt securities
|
—
|
|
9
|
|
9
|
|
|||
Total investments
|
—
|
|
189
|
|
189
|
|
|||
Restricted cash equivalents:
|
|
|
|
||||||
Money market mutual funds
|
48
|
|
—
|
|
48
|
|
|||
Commercial paper
|
20
|
|
—
|
|
20
|
|
|||
Total restricted cash equivalents
|
68
|
|
—
|
|
68
|
|
|||
Restricted investments:
|
|
|
—
|
|
|||||
U.S. treasuries
|
—
|
|
5
|
|
5
|
|
|||
Exchange traded fund
|
1
|
|
—
|
|
1
|
|
|||
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
Total restricted investments
|
1
|
|
7
|
|
8
|
|
|||
Total investments and restricted cash equivalents and investments
|
$
|
73
|
|
$
|
197
|
|
$
|
270
|
|
|
December 31, 2019
|
||||||||||
|
|
|
|
Fair Market Value
|
|||||||
(in millions)
|
Hedge type
|
Final settlement date
|
Notional amount
|
Other current assets
|
Accounts payable and other current liabilities
|
||||||
Derivatives designated as hedging instruments
|
|
|
|
|
|
||||||
Collar - LIBOR
|
Cash flow
|
May 2022
|
$
|
213
|
|
$
|
—
|
|
$
|
—
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
(in millions)
|
December 31, 2019
|
December 31, 2018
|
||||
Software
|
$
|
174
|
|
$
|
144
|
|
Office equipment, including data processing equipment
|
27
|
|
27
|
|
||
Leasehold improvements
|
24
|
|
21
|
|
||
Furniture, fixtures, and equipment
|
17
|
|
15
|
|
||
Projects in progress
|
3
|
|
2
|
|
||
Total
|
245
|
|
209
|
|
||
Less: Accumulated depreciation
|
(160
|
)
|
(130
|
)
|
||
Property and equipment, net
|
$
|
85
|
|
$
|
79
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Depreciation expense
|
$
|
41
|
|
$
|
35
|
|
$
|
28
|
|
Capitalized internally developed software costs
|
31
|
|
33
|
|
29
|
|
|||
Depreciation expense for capitalized internally developed software costs
|
29
|
|
24
|
|
17
|
|
|
|
December 31, 2019
|
December 31, 2018
|
||||||||||||||||
(in millions)
|
Weighted Average Amortization Period
|
Gross Carrying Amount
|
Accumulated Amortization
|
Net
Carrying Amount
|
Gross Carrying Amount
|
Accumulated Amortization
|
Net Carrying Amount
|
||||||||||||
Goodwill
|
|
$
|
289
|
|
$
|
—
|
|
$
|
289
|
|
$
|
289
|
|
$
|
—
|
|
$
|
289
|
|
Amortizable intangibles:
|
|
|
|
|
|
|
|
||||||||||||
Customer contracts
|
10 years
|
90
|
|
(76
|
)
|
14
|
|
90
|
|
(71
|
)
|
19
|
|
||||||
Developed technology
|
5 years
|
5
|
|
(4
|
)
|
1
|
|
5
|
|
(3
|
)
|
2
|
|
||||||
Total
|
|
$
|
95
|
|
$
|
(80
|
)
|
$
|
15
|
|
$
|
95
|
|
$
|
(74
|
)
|
$
|
21
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
Year ending December 31:
|
Amount
(in millions) |
||
2020
|
$
|
5
|
|
2021
|
4
|
|
|
2022
|
4
|
|
|
2023
|
2
|
|
|
Total
|
$
|
15
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Total accrued costs, beginning of year
|
$
|
238
|
|
$
|
255
|
|
$
|
255
|
|
Incurred
|
|
|
|
||||||
Current year
|
72
|
|
80
|
|
98
|
|
|||
Prior years
|
(31
|
)
|
(28
|
)
|
(6
|
)
|
|||
Total incurred
|
41
|
|
52
|
|
92
|
|
|||
Paid
|
|
|
|
||||||
Current year
|
(14
|
)
|
(12
|
)
|
(14
|
)
|
|||
Prior years
|
(51
|
)
|
(57
|
)
|
(78
|
)
|
|||
Total paid
|
(65
|
)
|
(69
|
)
|
(92
|
)
|
|||
Total accrued costs, end of year
|
$
|
214
|
|
$
|
238
|
|
$
|
255
|
|
(in millions)
|
|
December 31, 2019
|
December 31, 2018
|
||||
Total accrued costs, end of year
|
|
$
|
214
|
|
$
|
238
|
|
Collateral paid to carriers and offset against accrued costs
|
|
(9
|
)
|
(13
|
)
|
||
Total accrued costs, net of carrier collateral offset
|
|
$
|
205
|
|
$
|
225
|
|
|
|
|
|
||||
Payable in less than 1 year
(net of collateral paid to carriers of $3 as of December 31, 2019 and 2018)
|
|
$
|
61
|
|
$
|
67
|
|
Payable in more than 1 year
(net of collateral paid to carriers of $6 and $10 as of December 31, 2019 and 2018, respectively)
|
|
144
|
|
158
|
|
||
Total accrued costs, net of carrier collateral offset
|
|
$
|
205
|
|
$
|
225
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
(in millions)
|
December 31,
2019 |
December 31,
2018 |
||||
2018 Term Loan A
|
392
|
|
414
|
|
||
Total term loans
|
392
|
|
414
|
|
||
Deferred loan costs
|
(1
|
)
|
(1
|
)
|
||
Less: current portion
|
(22
|
)
|
(22
|
)
|
||
Long-term debt, noncurrent
|
$
|
369
|
|
$
|
391
|
|
|
|
|
||||
Annual contractual interest rate
|
3.42
|
%
|
4.15
|
%
|
||
Effective interest rate
|
3.52
|
%
|
4.25
|
%
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year ending December 31,
|
|
||||||||||||||||
(in millions)
|
2020
|
2021
|
2022
|
2023
|
2024
|
Thereafter
|
||||||||||||
Term loan repayments
|
$
|
22
|
|
$
|
22
|
|
$
|
22
|
|
$
|
326
|
|
$
|
—
|
|
$
|
—
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Number
of Shares |
Weighted
Average Exercise Price |
Weighted
Average Remaining Contractual Term
(in years)
|
Aggregate
Intrinsic Value (in millions) |
|||||
Balance at December 31, 2018
|
655,515
|
|
$
|
12.90
|
|
4.91
|
$
|
19
|
|
Exercised
|
(187,504
|
)
|
10.80
|
|
|
|
|
||
Expired
|
(6,000
|
)
|
0.50
|
|
|
|
|||
Balance at December 31, 2019
|
462,011
|
|
$
|
13.90
|
|
4.02
|
$
|
20
|
|
Exercisable at December 31, 2019
|
462,011
|
|
$
|
13.90
|
|
4.02
|
$
|
20
|
|
Vested and expected to vest at December 31, 2019
|
462,011
|
|
$
|
13.90
|
|
4.02
|
$
|
20
|
|
|
Year Ended December 31,
|
||||||||
Additional Disclosures for Stock Options (in millions)
|
2019
|
2018
|
2017
|
||||||
Total fair value of options vested
|
$
|
1
|
|
$
|
4
|
|
$
|
7
|
|
Total intrinsic value of options exercised
|
9
|
|
24
|
|
36
|
|
|||
Cash received from options exercised
|
2
|
|
7
|
|
11
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Time-based RSUs and RSAs
|
||||||||
|
Total Number
of RSUs
|
Total Number
of RSAs
|
Total Number
of Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||||
Nonvested at December 31, 2018
|
1,560,685
|
|
98,445
|
|
1,659,130
|
|
$
|
33.88
|
|
Granted
|
616,224
|
|
—
|
|
616,224
|
|
60.99
|
|
|
Vested
|
(891,633
|
)
|
(37,309
|
)
|
(928,942
|
)
|
32.53
|
|
|
Forfeited
|
(180,547
|
)
|
—
|
|
(180,547
|
)
|
38.89
|
|
|
Nonvested at December 31, 2019
|
1,104,729
|
|
61,136
|
|
1,165,865
|
|
$
|
48.47
|
|
|
Performance-based RSUs and RSAs
|
||||||||
|
Total Number
of RSUs
|
Total Number
of RSAs
|
Total Number Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||||
Nonvested at December 31, 2018
|
176,869
|
|
248,347
|
|
425,216
|
|
$
|
42.02
|
|
Granted
|
83,110
|
|
—
|
|
83,110
|
|
59.83
|
|
|
Vested
|
(155,589
|
)
|
(122,387
|
)
|
(277,976
|
)
|
39.45
|
|
|
Cancelled
|
(61,400
|
)
|
—
|
|
(61,400
|
)
|
61.75
|
|
|
Forfeited
|
(27,238
|
)
|
(11,103
|
)
|
(38,341
|
)
|
41.52
|
|
|
Nonvested at December 31, 2019
|
15,752
|
|
114,857
|
|
130,609
|
|
$
|
49.70
|
|
|
Time-based RSUs and RSAs
|
||||||||
|
Year Ended December 31,
|
||||||||
Additional Disclosures for equity-based plans
|
2019
|
2018
|
2017
|
||||||
Total grant date fair value of shares granted (in millions)
|
$
|
38
|
|
$
|
38
|
|
$
|
37
|
|
Total grant date fair value of shares vested (in millions)
|
$
|
30
|
|
$
|
28
|
|
$
|
21
|
|
Shares withheld to settle payroll tax liabilities related to vesting of shares held by employees
|
315,762
|
|
348,010
|
|
332,857
|
|
|
Performance-based RSUs and RSAs
|
||||||||
|
Year Ended December 31,
|
||||||||
Additional Disclosures for equity-based plans
|
2019
|
2018
|
2017
|
||||||
Total grant date fair value of shares granted (in millions)
|
$
|
4
|
|
$
|
14
|
|
$
|
10
|
|
Total grant date fair value of shares vested (in millions)
|
$
|
11
|
|
$
|
7
|
|
$
|
—
|
|
Shares withheld to settle payroll tax liabilities related to vesting of shares held by employees
|
135,877
|
|
110,222
|
|
2,244
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
|||||
(in millions)
|
2019
|
2018
|
2017
|
|||
Expected Term (in Years)
|
0.5
|
|
0.5
|
|
0.5
|
|
Expected Volatility
|
27-42%
|
|
27-37%
|
|
28-37%
|
|
Risk-Free Interest Rate
|
1.6-2.5%
|
|
1.42-2.5%
|
|
0.62-1.42%
|
|
Expected Dividend Yield
|
0
|
%
|
0
|
%
|
0
|
%
|
|
|
|
|
|||
Shares Issued under ESPP
|
207,324
|
|
175,966
|
|
224,928
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Cost of providing services
|
$
|
8
|
|
$
|
10
|
|
$
|
8
|
|
Sales and marketing
|
3
|
|
8
|
|
6
|
|
|||
General and administrative
|
28
|
|
22
|
|
14
|
|
|||
Systems development and programming costs
|
2
|
|
4
|
|
4
|
|
|||
Total stock based compensation expense
|
$
|
41
|
|
$
|
44
|
|
$
|
32
|
|
Total stock based compensation capitalized
|
$
|
1
|
|
$
|
—
|
|
$
|
—
|
|
Income tax benefit related to stock based compensation expense
|
$
|
11
|
|
$
|
11
|
|
$
|
7
|
|
Tax benefit realized from stock options exercised and similar awards
|
$
|
18
|
|
$
|
23
|
|
$
|
28
|
|
|
Amount
(in millions) |
Weighted-Average Period (in Years)
|
||
Nonvested stock options
|
$
|
—
|
|
0
|
Nonvested RSUs
|
51
|
|
2.27
|
|
Nonvested RSAs
|
2
|
|
0.49
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended
December 31, |
|||||
|
2019
|
2018
|
2017
|
|||
Shares issued and outstanding, beginning balance
|
70,596,559
|
|
69,818,392
|
|
69,015,690
|
|
Issuance of common stock from vested restricted stock units
|
1,036,119
|
|
1,634,271
|
|
1,020,352
|
|
Issuance of common stock from exercise of stock options
|
187,504
|
|
617,157
|
|
1,441,957
|
|
Issuance of common stock for employee stock purchase plan
|
207,324
|
|
175,966
|
|
224,928
|
|
Repurchase of common stock
|
(2,510,376
|
)
|
(1,190,995
|
)
|
(1,549,434
|
)
|
Awards effectively repurchased for required employee withholding taxes
|
(451,639
|
)
|
(458,232
|
)
|
(335,101
|
)
|
Shares issued and outstanding, ending balance
|
69,065,491
|
|
70,596,559
|
|
69,818,392
|
|
|
Year Ended
December 31, |
||||||||
(in millions, except per share data)
|
2019
|
2018
|
2017
|
||||||
Total cost
|
$
|
140
|
|
$
|
61
|
|
$
|
44
|
|
Total shares
|
2,510,376
|
|
1,190,995
|
|
1,549,434
|
|
|||
Average price per share
|
$
|
55.64
|
|
$
|
51.22
|
|
$
|
34.46
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Current:
|
|
|
|
||||||
Federal
|
$
|
53
|
|
$
|
41
|
|
$
|
46
|
|
State
|
12
|
|
7
|
|
1
|
|
|||
Total Current
|
65
|
|
48
|
|
47
|
|
|||
Deferred:
|
|
|
|
||||||
Federal
|
(2
|
)
|
(3
|
)
|
12
|
|
|||
State
|
(5
|
)
|
4
|
|
3
|
|
|||
Revaluation due to legislative changes
|
—
|
|
—
|
|
(40
|
)
|
|||
Total Deferred
|
(7
|
)
|
1
|
|
(25
|
)
|
|||
Total
|
$
|
58
|
|
$
|
49
|
|
$
|
22
|
|
|
Year Ended December 31,
|
|||||||||||||||||||||||
|
2019
|
2018
|
2017
|
|||||||||||||||||||||
(in millions, except percent)
|
Pre-Tax Income
|
Tax Expense/(Benefit)
|
Percent of Pre-Tax Income (Loss)
|
Pre-Tax Income
|
Tax Expense/(Benefit)
|
Percent of Pre-Tax Income (Loss)
|
Pre-Tax Income
|
Tax Expense/(Benefit)
|
Percent of Pre-Tax Income (Loss)
|
|||||||||||||||
|
$
|
270
|
|
|
|
$
|
241
|
|
|
|
$
|
200
|
|
|
|
|||||||||
U.S. federal statutory tax rate
|
|
$
|
57
|
|
21
|
%
|
|
$
|
51
|
|
21
|
%
|
|
$
|
70
|
|
35
|
%
|
||||||
State income taxes, net of federal benefit
|
|
20
|
|
7
|
|
|
18
|
|
8
|
|
|
10
|
|
5
|
|
|||||||||
Tax rate change
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(40
|
)
|
(20
|
)
|
|||||||||
Nondeductible meals, entertainment and penalties
|
|
1
|
|
—
|
|
|
1
|
|
—
|
|
|
1
|
|
—
|
|
|||||||||
Stock based compensation
|
|
(1
|
)
|
—
|
|
|
(9
|
)
|
(4
|
)
|
|
(15
|
)
|
(7
|
)
|
|||||||||
Uncertain tax positions
|
|
—
|
|
—
|
|
|
1
|
|
—
|
|
|
4
|
|
2
|
|
|||||||||
Tax credits
|
|
(7
|
)
|
(3
|
)
|
|
(5
|
)
|
(2
|
)
|
|
(4
|
)
|
(2
|
)
|
|||||||||
State and tax return to provision adjustments
|
|
(8
|
)
|
(3
|
)
|
|
(7
|
)
|
(3
|
)
|
|
(5
|
)
|
(3
|
)
|
|||||||||
Sec 199 benefits
|
|
(1
|
)
|
—
|
|
|
—
|
|
—
|
|
|
(3
|
)
|
(1
|
)
|
|||||||||
Other
|
|
(3
|
)
|
(1
|
)
|
|
(1
|
)
|
—
|
|
|
4
|
|
2
|
|
|||||||||
Total
|
|
$
|
58
|
|
21
|
%
|
|
$
|
49
|
|
20
|
%
|
|
$
|
22
|
|
11
|
%
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
|||||
(in millions)
|
2019
|
2018
|
||||
Deferred tax assets:
|
|
|
||||
Net operating losses (federal and state)
|
$
|
3
|
|
$
|
3
|
|
Accrued expenses
|
10
|
|
8
|
|
||
Accrued workers' compensation costs
|
9
|
|
9
|
|
||
Stock based compensation
|
3
|
|
8
|
|
||
Tax benefits relating to uncertain positions
|
1
|
|
—
|
|
||
Tax credits (federal and state)
|
7
|
|
7
|
|
||
Total
|
33
|
|
35
|
|
||
Valuation allowance
|
(5
|
)
|
(7
|
)
|
||
Total deferred tax assets
|
28
|
|
28
|
|
||
Deferred tax liabilities:
|
|
|
||||
Depreciation and amortization
|
(27
|
)
|
(24
|
)
|
||
Deferred service revenues
|
(41
|
)
|
(62
|
)
|
||
Prepaid health plan expenses
|
(1
|
)
|
—
|
|
||
Prepaid commission expenses
|
(19
|
)
|
(9
|
)
|
||
Total deferred tax liabilities
|
(88
|
)
|
(95
|
)
|
||
Net deferred tax liabilities
|
$
|
(60
|
)
|
$
|
(67
|
)
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Valuation allowance at January 1
|
$
|
7
|
|
$
|
7
|
|
$
|
6
|
|
Credited/ charged to net income
|
(2
|
)
|
—
|
|
1
|
|
|||
Valuation allowance at December 31
|
5
|
|
7
|
|
7
|
|
|
Year Ended December 31,
|
||||||||
(in millions)
|
2019
|
2018
|
2017
|
||||||
Unrecognized tax benefits at January 1
|
$
|
6
|
|
$
|
6
|
|
$
|
1
|
|
Additions for tax positions of prior periods
|
1
|
|
1
|
|
4
|
|
|||
Additions for tax positions of current period
|
1
|
|
—
|
|
1
|
|
|||
Reductions for tax positions of prior period:
|
|
|
|
||||||
Lapse of applicable statute of limitations
|
(1
|
)
|
(1
|
)
|
—
|
|
|||
Unrecognized tax benefits at December 31
|
$
|
7
|
|
$
|
6
|
|
$
|
6
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Year Ended December 31,
|
||||||||
(in millions, except per share data)
|
2019
|
2018
|
2017
|
||||||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
Weighted average shares of common stock outstanding
|
70
|
|
70
|
|
69
|
|
|||
Basic EPS
|
$
|
3.04
|
|
$
|
2.72
|
|
$
|
2.57
|
|
|
|
|
|
||||||
Net income
|
$
|
212
|
|
$
|
192
|
|
$
|
178
|
|
Weighted average shares of common stock outstanding
|
70
|
|
70
|
|
69
|
|
|||
Dilutive effect of stock options and restricted stock units
|
1
|
|
2
|
|
2
|
|
|||
Weighted average shares of common stock outstanding
|
71
|
|
72
|
|
71
|
|
|||
Diluted EPS
|
$
|
2.99
|
|
$
|
2.65
|
|
$
|
2.49
|
|
|
|
|
|
||||||
Common stock equivalents excluded from income per
diluted share because of their anti-dilutive effect
|
1
|
|
1
|
|
2
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
Quarter ended
|
|||||||||||
(in millions, except per share data)
|
March 31
|
June 30
|
September 30
|
December 31
|
||||||||
2019
|
|
|
|
|
||||||||
Total revenues
|
$
|
934
|
|
$
|
935
|
|
$
|
969
|
|
$
|
1,018
|
|
Insurance costs
|
683
|
|
704
|
|
748
|
|
792
|
|
||||
Operating income
|
82
|
|
55
|
|
68
|
|
63
|
|
||||
Net income
|
63
|
|
46
|
|
55
|
|
48
|
|
||||
Basic net income per share
|
$
|
0.91
|
|
$
|
0.65
|
|
$
|
0.80
|
|
$
|
0.69
|
|
Diluted net income per share
|
$
|
0.89
|
|
$
|
0.64
|
|
$
|
0.78
|
|
$
|
0.68
|
|
2018
|
|
|
|
|
||||||||
Total revenues
|
$
|
861
|
|
$
|
850
|
|
$
|
875
|
|
$
|
917
|
|
Insurance costs
|
641
|
|
630
|
|
647
|
|
692
|
|
||||
Operating income
|
71
|
|
76
|
|
62
|
|
42
|
|
||||
Net income
|
54
|
|
58
|
|
51
|
|
29
|
|
||||
Basic net income per share
|
$
|
0.77
|
|
$
|
0.82
|
|
$
|
0.73
|
|
$
|
0.41
|
|
Diluted net income per share
|
$
|
0.75
|
|
$
|
0.80
|
|
$
|
0.71
|
|
$
|
0.40
|
|
|
|
|
DISCLOSURE CONTROLS AND PROCEDURES
|
|
i.
|
information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure and
|
ii.
|
such information is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.
|
|
|
|
MANAGEMENT AND CERTAIN SECURITY HOLDERS
|
|
|
|
|
FINANCIAL STATEMENT SCHEDULES
|
|
|
|
|
EXHIBITS
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Exhibit
No.
|
|
Description of Exhibit
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing
|
|
Filed
Herewith
|
|
|
|
|
|
|
|
|
|||||||
3.1
|
|
|
8-K
|
|
001-36373
|
|
3.1
|
|
|
4/1/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
|
10-Q
|
|
001-36373
|
|
3.1
|
|
|
11/2/2017
|
|
|
|
|
|
|
|
|
|
|
|||||||
3.3
|
|
|
S-1/A
|
|
333-192465
|
|
3.4
|
|
|
3/4/2014
|
|
|
|
|
|
|
|
|
|
|
|||||||
4.1
|
|
|
8-K
|
|
001-36373
|
|
4.1
|
|
|
2/2/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.2
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1*
|
|
|
S-1/A
|
|
333-192465
|
|
10.3
|
|
|
3/14/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2*
|
|
|
|
10-Q
|
|
001-36373
|
|
10.1
|
|
|
5/8/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.3*
|
|
|
S-1/A
|
|
333-192465
|
|
10.4
|
|
|
3/4/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4*
|
|
|
S-1/A
|
|
333-192465
|
|
10.6
|
|
|
3/4/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.5*
|
|
|
10-Q
|
|
001-36373
|
|
10.1
|
|
|
4/30/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.6*
|
|
|
10-Q
|
|
001-36373
|
|
10.2
|
|
|
4/30/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7*
|
|
|
10-Q
|
|
001-36373
|
|
10.3
|
|
|
4/30/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.8*
|
|
|
|
10-Q
|
|
001-36373
|
|
10.4
|
|
|
4/30/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.9*
|
|
|
10-Q
|
|
001-36373
|
|
10.2
|
|
|
4/29/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXHIBITS
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Exhibit
No.
|
|
Description of Exhibit
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing
|
|
Filed
Herewith
|
|
10.10*
|
|
|
10-Q
|
|
001-36373
|
|
10.3
|
|
|
4/29/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11*
|
|
|
10-Q
|
|
001-36373
|
|
10.1
|
|
|
7/25/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.12*
|
|
|
10-Q
|
|
001-36373
|
|
10.2
|
|
|
7/25/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13*
|
|
|
S-1/A
|
|
333-192465
|
|
10.7
|
|
|
3/14/2014
|
|
|
|
|
|
|
|
|
|
|
|||||||
10.14*
|
|
|
8-K
|
|
001-36373
|
|
N/A
|
|
|
3/11/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.15*
|
|
|
10-K
|
|
001-36373
|
|
10.7
|
|
|
2/27/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.16*
|
|
|
10-K
|
|
001-36373
|
|
10.10
|
|
|
4/1/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.17*
|
|
|
8-K
|
|
001-36373
|
|
10.1
|
|
|
5/23/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.18*
|
|
|
10-Q
|
|
001-36373
|
|
10.5
|
|
|
4/30/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.19
|
|
|
S-1/A
|
|
333-192465
|
|
10.8
|
|
|
3/4/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.20*
|
|
|
S-1/A
|
|
333-192465
|
|
10.9
|
|
|
2/13/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.21*
|
|
|
10-Q
|
|
001-36373
|
|
10.1
|
|
|
8/1/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.22*
|
|
|
10-Q
|
|
001-36373
|
|
10.2
|
|
|
8/1/2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.23*
|
|
|
10-K
|
|
001-36373
|
|
10.15
|
|
|
2/27/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.24*
|
|
|
10-K
|
|
001-36373
|
|
10.22
|
|
|
2/14/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.25*
|
|
|
|
10-Q
|
|
001-36373
|
|
10.1
|
|
|
4/29/2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.26*
|
|
|
8-K
|
|
001-36373
|
|
10.1
|
|
|
12/22/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXHIBITS
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Exhibit
No.
|
|
Description of Exhibit
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing
|
|
Filed
Herewith
|
|
10.27*
|
|
|
8-K
|
|
001-36373
|
|
10.1
|
|
|
6/22/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.1
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.1
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1**
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCHCAL
|
|
Inline XBRL Taxonomy Extension SchemaCalculation Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CALDEF
|
|
Inline XBRL Taxonomy Extension CalculationDefinition Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEFLAB
|
|
Inline XBRL Taxonomy Extension DefinitionLabel Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LABPRE
|
|
Inline XBRL Taxonomy Extension LabelPresentation Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE104
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.Cover Page Interactive Data File (embedded with the Inline XBRL document).
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Constitutes a management contract or compensatory plan or arrangement.
|
||||||||||||
**
|
Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.
|
|
|
|
SIGNATURES
|
|
|
TRINET GROUP, INC.
|
||
|
|
||
Date: February 13, 2020
|
|
By:
|
/s/ Burton M. Goldfield
|
|
|
|
Burton M. Goldfield
|
|
|
|
Chief Executive Officer
|
|
|
|
|
Date: February 13, 2020
|
|
By:
|
/s/ Richard Beckert
|
|
|
|
Richard Beckert
|
|
|
|
Chief Financial Officer
|
|
|
|
SIGNATURES
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Burton M. Goldfield
|
|
Chief Executive Officer (principal executive officer)
|
|
February 13, 2020
|
Burton M. Goldfield
|
|
|
||
|
|
|
|
|
/s/ Richard Beckert
|
|
Chief Financial Officer (principal financial officer)
|
|
February 13, 2020
|
Richard Beckert
|
|
|
||
|
|
|
|
|
/s/ Michael P. Murphy
|
|
Chief Accounting Officer (principal accounting officer)
|
|
February 13, 2020
|
Michael P. Murphy
|
|
|
||
|
|
|
|
|
/s/ Michael J. Angelakis
|
|
Director
|
|
February 13, 2020
|
Michael J. Angelakis
|
|
|
||
|
|
|
|
|
/s/ Katherine August-deWilde
|
|
Director
|
|
February 13, 2020
|
Katherine August-deWilde
|
|
|
||
|
|
|
|
|
/s/ Martin Babinec
|
|
Director
|
|
February 13, 2020
|
Martin Babinec
|
|
|
||
|
|
|
|
|
/s/ H. Raymond Bingham
|
|
Director
|
|
February 13, 2020
|
H. Raymond Bingham
|
|
|
||
|
|
|
|
|
/s/ Paul Chamberlain
|
|
Director
|
|
February 13, 2020
|
Paul Chamberlain
|
|
|
||
|
|
|
|
|
/s/ Kenneth Goldman
|
|
Director
|
|
February 13, 2020
|
Kenneth Goldman
|
|
|
||
|
|
|
|
|
/s/ Shawn Guertin
|
|
Director
|
|
February 13, 2020
|
Shawn Guertin
|
|
|
||
|
|
|
|
|
/s/ David C. Hodgson
|
|
Director
|
|
February 13, 2020
|
David C. Hodgson
|
|
|
||
|
|
|
|
|
/s/ Dr. Jacqueline Kosecoff
|
|
Director
|
|
February 13, 2020
|
Dr. Jacqueline Kosecoff
|
|
|
||
|
|
|
|
|
/s/ Wayne B. Lowell
|
|
Director
|
|
February 13, 2020
|
Wayne B. Lowell
|
|
|
|
|
|
•
|
before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
|
•
|
upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i) persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
|
•
|
on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.
|
•
|
any merger or consolidation involving the corporation and the interested stockholder;
|
•
|
any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
|
•
|
subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
|
•
|
any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or
|
•
|
the receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.
|
|
||||
|
|
|
|
|
Company Name
|
|
DBA/AKA
|
|
Incorporation
Jurisdiction
|
210 Park Avenue Holding, Inc.
|
|
|
|
Oklahoma
|
Accord Human Resources 12, Inc.
|
|
|
|
Florida
|
Accord Technology, LLC
|
|
|
|
Oklahoma
|
Ambrose Advisory Services, LLC
|
|
|
|
New York
|
App7, Inc.
|
|
ExpenseCloud
|
|
Delaware
|
Archimedes Risk Solutions, Ltd.
|
|
|
|
Bermuda
|
Gevity Insurance Agency, Inc.
|
|
|
|
Delaware
|
Mosaic By Accord, LLC
|
|
|
|
Oklahoma
|
SOI Employee Benefit Trust
|
|
|
|
North Carolina
|
SOI Holdings, Inc.
|
|
|
|
Delaware
|
SOI, Inc.
|
|
|
|
Delaware
|
TriNet Employee Benefit Insurance Trust
|
|
|
|
California
|
TriNet Employer Group Canada, Inc.
|
|
TriNet
|
|
Ontario
|
TriNet Holdings A, Inc.
|
|
|
|
Delaware
|
TriNet Holdings B, Inc.
|
|
|
|
Delaware
|
TriNet HR I, Inc.
|
|
Accord
|
|
Oklahoma
|
TriNet HR II, Inc.
|
|
Amlease
|
|
Delaware
|
TriNet HR II Holdings, Inc.
|
|
Strategic Outsourcing
|
|
Delaware
|
TriNet HR II-A, Inc.
|
|
SOI-23
|
|
Florida
|
TriNet HR III, Inc.
|
|
TriNet
|
|
California
|
TriNet HR III-A, Inc.
|
|
TriNet
|
|
Delaware
|
TriNet HR III-B, Inc.
|
|
TriNet
|
|
Delaware
|
TriNet HR IV, LLC
|
|
Ambrose
|
|
New York
|
TriNet HR XI, Inc.
|
|
TriNet
|
|
Delaware
|
TriNet Insurance Brokerage, Inc.
|
|
|
|
Delaware
|
TriNet Insurance Services, Inc.
|
|
|
|
California
|
TriNet Professional Employer Services, Inc.
|
|
|
|
Delaware
|
TriNet USA, Inc.
|
|
|
|
Delaware
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
(a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Burton M. Goldfield
|
|
|
Burton M. Goldfield
|
|
|
President and Chief Executive Officer
|
|
|
(a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
(a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Richard Beckert
|
|
|
Richard Beckert
|
|
|
Chief Financial Officer
|
|
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
|
February 13, 2020
|
|
/s/ Burton M. Goldfield
|
|
|
|
|
Burton M. Goldfield
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
/s/ Richard Beckert
|
Date:
|
|
February 13, 2020
|
|
Richard Beckert
|
|
|
|
|
Chief Financial Officer
|